Article History
Received: 5 May 2021
Accepted: 7 July 2021
First Online: 16 August 2021
Declarations
:
: S.A. Mousa has a patent related to P-bi-TAT and he is a founder of NanoPharmaceuticals LLC, which is developing anticancer drugs. All other authors declare no conflicts of interest.